Retatrutide-Associated Lean Mass Preservation Strategy
Retatrutide treatment is associated with reductions in total fat mass with lean mass loss occurring in parallel, rather than disproportionately. [1] Muscle mass preservation during retatrutide therapy is supported by resistance exercise plus adequate protein intake. [2]
Expected Body Composition Changes With Retatrutide
In adults with type 2 diabetes, retatrutide produced dose-dependent reductions in total fat mass assessed by DXA over 36 weeks. [1] The substudy interpretation reported that the proportion of lean mass loss to weight loss was similar to other obesity treatments. [1]
Protein Intake Targets During Weight Loss
Progressive muscle wasting prevention relies on increased dietary protein during calorie restriction. [2] Many sarcopenia management guidance statements recommend at least 1.2 g protein/kg/day for older adults. [2] Protein intake may be increased further in the presence of catabolic conditions or ongoing muscle wasting. [2]
Resistance Exercise to Counter Weight Loss–Associated Muscle Loss
Progressive resistance (strength) training is recommended as a first-line therapy for sarcopenia management. [2] Exercise intervention should be combined with nutrition intervention for older adults with sarcopenia. [2] Multi-component exercise patterns used in obesity management include resistance training as part of the physical activity plan. [3]
Calorie Deficit Management to Reduce Lean Tissue Loss
Weight loss therapy should aim to minimize muscle and bone loss during energy restriction. [3] A diet-based energy deficit approach of approximately 500 kcal/day has been used in obesity management guidance frameworks for the elderly. [3]
Nutritional Co-Factors Supporting Lean Tissue
Obesity management frameworks in older adults include ensuring adequate calcium and vitamin D intake alongside dietary protein. [3]
Practical Monitoring for Lean Mass Preservation
Body composition monitoring should be used when feasible during anti-obesity therapy to detect disproportionate lean mass loss. [1] Performance and strength assessment support the detection of functional decline consistent with muscle loss. [2]
Common Pitfalls to Avoid
Aggressive energy restriction without attention to protein adequacy increases risk for muscle wasting during weight loss therapy. [2][3] Exercise-only approaches without concurrent nutrition targets reduce the likelihood of preserving muscle mass in sarcopenia-focused guidance. [2]